COMMUNIQUÉS West-GlobeNewswire

Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases
09/07/2026
CHICAGO, July 09, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/07/2026
BEDFORD, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Barrier
09/07/2026
Denali co-founder and CEO Ryan Watts, Ph.D., to deliver opening plenary address at 2026 AAIC in London on July 12, 2026 Presentation will highlight recent scientific advances and future opportunities to accelerate [...]
Oh!mino Survey Finds GLP-1 Muscle Loss Concerns Drive New Focus on Preserving Muscle While Dieting
09/07/2026
Seal Beach, CA, July 09, 2026 (GLOBE NEWSWIRE) -- Oh!Nutrition, a California-based nutritional product development company, has released company survey findings from more than 500 Oh!mino users taking GLP-1 medications [...]
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
09/07/2026
PORTLAND, Maine, July 09, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf [...]
Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants
09/07/2026
Daix (France), New York City (New York, United States), July 9, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the development [...]
L’Agence des médicaments du Canada émet une recommandation favorable au remboursement d’EMPAVELI (pegcétacoplan) dans le traitement de la C3G et de la IC-MPGN primaire
09/07/2026
Cette recommandation constitue une avancée majeure vers l’amélioration de l’accès aux soins pour les Canadiens atteints de néphropathies rares WALTHAM, Mass., 09 juill. 2026 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum [...]
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
09/07/2026
SEATTLE, July 09, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
09/07/2026
WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the [...]
Amneal to Report Second Quarter 2026 Results on July 30, 2026
09/07/2026
BRIDGEWATER, N.J., July 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced it will report second quarter 2026 financial results on Thursday, July 30, [...]
Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
09/07/2026
Entered into global collaboration with Roche for bexobrutideg, with potential total payments of up to $2.3 billion, including $700 million upfront payment Co-development, co-commercialization collaboration includes [...]
Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates
09/07/2026
~ Collaboration will leverage the RaniPill® platform to explore oral delivery of PegBio's proprietary portfolio of novel obesity and metabolic disease molecules ~ ~ Agreement expands Rani's obesity franchise beyond its [...]
Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
09/07/2026
BANNOCKBURN, Ill., July 09, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced [...]
Canada’s Drug Agency Issues Positive Reimbursement Recommendation for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
09/07/2026
This recommendation represents an important step towards improving access for Canadians living with rare kidney diseases WALTHAM, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: [...]
Tilray Medical Announces Commercial Launch of Medical Cannabis in Panama, Expanding Patient Access Across Latin America
09/07/2026
Launch of Tilray Medical's first medical cannabis product in Panama strengthens the company's international footprint and supports broader access to regulated cannabinoid-based medicines PANAMA CITY, July 09, 2026 ( [...]
20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth
09/07/2026
Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage Detection GAITHERSBURG, Md., July 09, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. ( [...]
Inventiva annonce la finalisation de la restructuration des BSA BEI à la suite de l'émission des Nouveaux BSA BEI
09/07/2026
Daix (France), New York City (New York, États-Unis), le 9 juillet, 2026 – Inventiva (Euronext Paris et NASDAQ : IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d'une [...]
Ipsen - June 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
09/07/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Juin 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
09/07/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]

Pages